SCHEMBL26053794

SCHEMBL26053794

CN(C)c1ccc2c3c(cccc13)C(=O)N(CCN)C2=O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 8/20 0.69
▸ KMT2A Q03164 8/20 0.69
▸ POLB P06746 5/20 0.69
▸ USP2 O75604 4/20 0.59
▸ HEXA P06865 4/20 0.57
▸ HEXB P07686 4/20 0.57
▸ ALDH1A1 P00352 3/20 0.51
▸ LMNA P02545 3/20 0.51
▸ PABPC1 P11940 2/20 0.51
▸ KDM4E B2RXH2 2/20 0.51
▸ MAPT P10636 2/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ KEAP1 Q14145 3/20 0.50
▸ NFE2L2 Q16236 3/20 0.50
▸ TLR9 Q9NR96 2/20 0.50
▸ CYP1B1 Q16678 3/20 0.49
▸ ATM Q13315 3/20 0.49
▸ NPSR1 Q6W5P4 2/20 0.47
▸ CCR6 P51684 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31094030 1.00 MEN1 (0.69) MEN1KMT2APOLBUSP2HEXA
SCHEMBL29581442 0.89 MEN1 (0.61) MEN1KMT2APOLBUSP2HEXA
SCHEMBL29580722 0.86 MEN1 (0.59) MEN1KMT2APOLBUSP2HEXA
SCHEMBL3504382 0.86 MEN1 (0.69) MEN1KMT2APOLBUSP2HEXA
SCHEMBL3503912 0.86 MEN1 (0.69) MEN1KMT2APOLBUSP2HEXA
SCHEMBL16213594 0.86 MEN1 (0.69) MEN1KMT2APOLBUSP2HEXA
SCHEMBL29581473 0.85 MEN1 (0.57) MEN1KMT2APOLBUSP2HEXA
SCHEMBL23373805 0.85 MEN1 (0.64) MEN1KMT2APOLBUSP2HEXA
SCHEMBL29580895 0.84 MEN1 (0.56) MEN1KMT2APOLBUSP2HEXA
SCHEMBL3502546 0.84 MEN1 (0.66) MEN1KMT2APOLBUSP2HEXA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230331679-A1 NAPHTHALENE MONOIMIDE COMPOUNDS AND METHODS THEREOF JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH (IN) 2023-10-19 — — US disclosed
US-20230271983-A1 FUNCTIONALIZED ISONITRILES AND PRODUCTS, PREPARATION AND USES THEREOF UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) 2023-08-31 — — US disclosed
US-20230271983-A1 FUNCTIONALIZED ISONITRILES AND PRODUCTS, PREPARATION AND USES THEREOF UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) 2023-08-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230331679-A1 NAPHTHALENE MONOIMIDE COMPOUNDS AND METHODS THEREOF PSEN1, PSEN2, MAPT MEN1 521/4885KMT2A 4003/4885POLB 3426/4885
US-20230271983-A1 FUNCTIONALIZED ISONITRILES AND PRODUCTS, PREPARATION AND USES THEREOF KIT, MACF1, IK MEN1 1772/4885KMT2A 3253/4885POLB 2955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback